TREXIMET - 21695-954-09 - (sumatriptan succinate and naproxen sodium)

Alphabetical Index


Drug Information of TREXIMET

Product NDC: 21695-954
Proprietary Name: TREXIMET
Non Proprietary Name: sumatriptan succinate and naproxen sodium
Active Ingredient(s): 500; 85    mg/1; mg/1 & nbsp;   sumatriptan succinate and naproxen sodium
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of TREXIMET

Product NDC: 21695-954
Labeler Name: Rebel Distributors Corp
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021926
Marketing Category: NDA
Start Marketing Date: 20080425

Package Information of TREXIMET

Package NDC: 21695-954-09
Package Description: 9 TABLET, FILM COATED in 1 CONTAINER (21695-954-09)

NDC Information of TREXIMET

NDC Code 21695-954-09
Proprietary Name TREXIMET
Package Description 9 TABLET, FILM COATED in 1 CONTAINER (21695-954-09)
Product NDC 21695-954
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name sumatriptan succinate and naproxen sodium
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20080425
Marketing Category Name NDA
Labeler Name Rebel Distributors Corp
Substance Name NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE
Strength Number 500; 85
Strength Unit mg/1; mg/1
Pharmaceutical Classes Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC],Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC]

Complete Information of TREXIMET


General Information